Skip to main content

Advertisement

Volume 10 Supplement 1

de Senectute: Age and Health Forum

Medical treatment of actinic keratoses and superficial skin cancers: diclofenac

Article metrics

  • 802 Accesses

In patients who develop early signs of fotocarcinogenesi, the actinic keratosis are one of the most frequent events that can lead to problems of therapeutic management, especially if for business reasons or lifestyle, they are repeatedly and chronically exposed to the sun. In these patients the lesions are often widespread and recurrent, and may require repeated treatment cycles.

It is in these cases that treatment with topical diclofenac 3% gel hyaluronic acid can provide good results thanks to its efficacy, tolerability, the patient compliance and excellent cosmetic results compared to other conventional therapies.

It presents a brief review of clinical cases with the treatment modality and they discuss the indications and efficacy.

Author information

Correspondence to G Valenti.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Valenti, G. Medical treatment of actinic keratoses and superficial skin cancers: diclofenac. BMC Geriatr 10, L48 (2010) doi:10.1186/1471-2318-10-S1-L48

Download citation

Keywords

  • Hyaluronic Acid
  • Skin Cancer
  • Clinical Case
  • Conventional Therapy
  • Patient Compliance